The Biodefense market size is USD 18.3 Bn in 2026.
The Biodefense market is projected to grow at a CAGR of 5% by 2033.
The Biodefense market growth drivers include rising infectious diseases, increasing bioterrorism threats, and higher government funding for R&D.
North America is a dominating region for the Biodefense market.
Emergent BioSolutions Inc., SIGA Technologies Inc., Bavarian Nordic A/S, GSK plc, and Sanofi are some leading industry players in the Biodefense market.